WORX

The Week

SCWorx (WORX) rose 58.7% this week to close at $2.19, outperforming the S&P 500 by about 59.17 percentage points. The week was marked by a violent upswing and a sharp pullback, with an amplitude of 232.37%. Monday (19 October) opened at $1.39 and ran up to $3.77 intraday before settling at $2.68; Tuesday (20 October) pushed higher to $4.58, the week’s high, and ended at $3.66. From Wednesday the tape reversed: the stock closed at $2.42 on Wednesday, bounced to $2.61 on Thursday, and slid back to $2.19 on Friday. Weekly turnover was 213 million shares, with average daily volume roughly 24.8x the 60-day median.

Key Events

The central company news arrived on Monday morning, 19 October, when SCWorx said it had signed an agreement with a healthcare system to supply healthcare supply chain data management services. The stock jumped more than 42% at one point during Monday trading, with headlines linking the move to the healthcare data announcement. Momentum carried into Tuesday, when shares reached $4.58, more than 2.3x the prior week’s close. Wednesday flipped the tone: the stock was down about 10% in pre-market and fell as much as 33.61% during regular hours, with media commentary pointing to compliance risks and exaggerated moves, though no formal company statement accompanied that swing. After Friday’s close, SCWorx filed an updated S-3/A, the only material filing of the week. The latest after-hours quote stood at $2.243.

The Week Ahead

SCWorx is scheduled to report fiscal Q3 2026 results on 12 November, which is the next hard catalyst for the company. Investors will be watching for the revenue impact of the new healthcare system agreement, margin trends and operating cash flow. The macro calendar is front-loaded: the Dallas Fed manufacturing business activity index arrives on 26 October, followed by durable goods orders, FHFA house prices, Case Shiller home prices, new home sales, the Richmond Fed composite index and consumer confidence on 27 October. For a small-cap name like WORX, these releases are mostly a backdrop rather than a direct driver, but with this kind of volatility, shifts in market sentiment can still amplify the stock’s short-term swings.

In Short

WORX’s move this week paired a single healthcare supply chain agreement with a very thin float: the stock gained 58.7% but then gave back a large chunk of the intraday spike, leaving the week’s range at $2.19 to $4.58. The valuation picture is mixed: book value per share is $6.4992, so the stock trades at 0.34x book, with a market value of roughly $2.34 million and only about 1.05 million shares outstanding. Earnings, however, are still negative, with TTM EPS at -$2.2092. On the latest trading day, small and medium-sized flows were net sellers, while large-lot flows showed no clear direction. The real question now is whether the 12 November results can turn the healthcare system deal into verifiable financials, and whether the liquidity-driven churn holds up through a data-heavy macro week.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.